Palero, Celestino .
HRN: 17-42-32 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2026
MUPIROCIN 2%, 15G (TUBE)
04/11/2026
04/17/2026
TOPICAL
APPLY ON AFFECTED AREAS
OD
INFECTED WOUND
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: